Cargando…
Comparative Gene Signature of (−)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights
Triple negative breast cancer (TNBC) heterogeneity and limited therapeutic options confer its phenotypic aggressiveness. The discovery of anti-TNBC natural products with valid molecular target(s) and defined pharmacodynamic profile would facilitate their therapeutic nutraceutical use by TNBC patient...
Autores principales: | Qusa, Mohammed H., Abdelwahed, Khaldoun S., Siddique, Abu Bakar, El Sayed, Khalid A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157589/ https://www.ncbi.nlm.nih.gov/pubmed/34069906 http://dx.doi.org/10.3390/nu13051706 |
Ejemplares similares
-
(-)-Oleocanthal Nutraceuticals for Alzheimer’s Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice Model
por: Tajmim, Afsana, et al.
Publicado: (2021) -
S-(−)-Oleocanthal Ex Vivo Modulatory Effects on Gut Microbiota
por: Qusa, Mohammed H., et al.
Publicado: (2023) -
Safety Evaluations of Single Dose of the Olive Secoiridoid S-(−)-Oleocanthal in Swiss Albino Mice
por: Siddique, Abu Bakar, et al.
Publicado: (2020) -
Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2
por: Siddique, Abu Bakar, et al.
Publicado: (2022) -
Optimization of Taste-Masked (–)-Oleocanthal Effervescent Formulation with Potent Breast Cancer Progression and Recurrence Suppressive Activities
por: Tajmim, Afsana, et al.
Publicado: (2019)